Alzheimer's drug Leqembi launched, nausea Apple Vision Pro
Good afternoon! The launch of the closely watched Alzheimer's drug Leqembi is off to a slow start. Even so, the…
health care industry
Doctors Feeling Exhausted But Encouraged by AI's Potential, Survey Finds
Suriyapong Thongsawang | Moment | fake images Doctors in the United States are struggling to deal with burnout, staffing shortages…
AbbVie taps Robert Michael as CEO, replacing Richard González
Test tubes are seen in front of an AbbVie logo in this illustration taken on May 21, 2021. Ruvic Dice…
What you need to know about health coverage for new weight loss drugs
Many American companies are dealing with health insurance coverage issues for workers when it comes to GLP-1 weight loss drugs.…
In this fast-paced bull market, we are increasing our Club price targets by 4 stocks
It's been difficult to keep up. That's the story of this year's big stock winners. They keep winning and winning…
What Eli Lilly Investors Can Learn from the Slow Launch of a Rival Drug
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…
FTC and HHS Examine Cause of Generic Drug Shortages
A variety of generic pills and capsules. Nenov | Moment | fake images The Federal Trade Commission said Wednesday that…
Jim Cramer praises GE after US regulatory approval to develop nuclear fuel
CNBC's Jim Cramer called General Electric a winner in the industrial sector because of the advances it is making in…
Higher medical costs are hitting CVS and UnitedHealth
A UnitedHealth Group health insurance card is seen in a wallet, Oct. 14, 2019. Lucy Nicholson | Reuters Good afternoon!…
Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…